Sanofi (SNY), Regeneron (REGN) Report Additional Positive Data from Study 1003 in Patients w/ heFH
Tweet Send to a Friend
Sanofi (NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced additional positive results from a Phase 2 trial of SAR236553/REGN727 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
